The most important therapeutic goals for treating rheumatoid arthritis (RA) are eliminating signs and symptoms (such as joint pain, swelling, and stiffness); preventing joint damage or its progression; and maximizing physical function and quality of life. These aims are accomplished by achieving disease remission, a state in which no or only minimal residual inflammation is discernible. Today, this goal is attainable in up to 50% of patients with RA, using approved drugs in a treat-to-target strategy.1
Aletaha D, Smolen JS. Achieving Clinical Remission for Patients With Rheumatoid Arthritis. JAMA. 2019;321(5):457–458. doi:10.1001/jama.2018.21249
Customize your JAMA Network experience by selecting one or more topics from the list below.
Create a personal account or sign in to: